Message from the Organizing Committee of the International Workshop on Liver and Gut Fibrosis in light of the current COVID-19 crisis:
Due to the current COVID-19 pandemic we feel we have no choice but to postpone the International Workshop on Liver and Gut Fibrosis, which was scheduled to take place 18th-19th June 2020 in Valencia, Spain.
We are currently considering alternative dates for the workshop, which will take place in Valencia at the same venue, and will publish them here on the website as soon as possible.
Registrations will be maintained, while a full refund will be provided to those who request it.
We look forward to seeing you in the not-to-distant future. In the meantime, our thoughts and best wishes go out to patients and their families and to the brave healthcare professionals struggling to contain the pandemic across the globe.
Prof. Juan V. Esplugues
Head of the
Fibrosis is a global health problem characterized by an excessive growth of fibrous tissue due to chronic inflammation and altered tissue remodelling and repair processes. It occurs in various organs, including the lung, kidney, liver and intestine, and is a key component of important pathologies, including cystic fibrosis, Crohn’s Disease and Non-Alcoholic Fatty Liver Disease. Despite the huge advances made by research in recent years, the molecular mechanisms involved in the development of fibrosis are still unclear; indeed, it would seem that different mechanisms are involved in each of the affected organs. Importantly, few effective therapeutic options are available, and only for some organs, such as the lung and kidney, with no anti-fibrotic pharmacological treatments available for the intestine or liver. The International Workshop on Liver and Gut Fibrosis – the first to take place, and endorsed by EASL – has been organised to bring together basic scientists and clinical experts working in the field with the purpose of focusing on the molecular mechanisms involved in the different types of fibrosis and determining those that are common to different organs, particularly the gut and liver. In this way, the workshop has been designed to explore options that might improve current therapeutic approaches and to identify new pharmacological targets that will relieve the burden of fibrosis for millions of patients.
Deadline for travel grant application:
Notification of abstract acceptance:
PhD students and
REGISTRATION NOW OPEN